/
/
/

Gujarat Kidney And Super Speciality Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
---743%
--355%454%
----
64%64%76%69%

Peer Comparison

Symbol
APOLLOHOSP
MAXHEALTH
MANIPALHOS
FORTIS
ASTERDM
NH
MEDANTA
LALPATHLAB
KIMS
AGARWALEYE
GKSL
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
8,687.5₹126300 Cr60.4540.39207.67₹1942 Cr
998.5₹96763 Cr66.423.3119.84₹1442 Cr
732.25₹95496 Cr107.021.9611.95₹892 Cr
911.8₹68901 Cr65.753.5320.1₹1042 Cr
786.55₹68592 Cr215.240.316.76₹464 Cr
1,878₹38439 Cr47.110.1465.36₹806 Cr
1,473.3₹38149 Cr68.595.9129.85₹556 Cr
1,875.9₹32259 Cr59.5310.1142.51₹505 Cr
770.8₹32231 Cr157.771.0412.74₹241 Cr
510.85₹16249 Cr109.521.4313.88₹133 Cr
172.68₹1354 Cr85.520.662.66₹17 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
₹34 Cr₹31 Cr₹23 Cr₹13 Cr₹15 Cr₹10 Cr₹12 Cr₹9 Cr
₹69 L₹71 L₹6 L₹9 L₹80,000₹5 L₹5 L₹5 L
₹35 Cr₹31 Cr₹23 Cr₹13 Cr₹15 Cr₹10 Cr₹12 Cr₹9 Cr
₹27 Cr₹26 Cr₹18 Cr₹9 Cr₹8 Cr₹8 Cr₹8 Cr₹5 Cr
₹9 Cr₹7 Cr₹7 Cr₹5 Cr₹9 Cr₹3 Cr₹5 Cr₹5 Cr
₹66 L₹82 L₹60 L₹28 L₹18 L₹16 L₹17 L₹16 L
₹7 Cr₹5 Cr₹5 Cr₹4 Cr₹7 Cr₹2 Cr₹4 Cr₹4 Cr
₹5 Cr₹5 Cr₹4 Cr₹3 Cr₹5 Cr₹1 Cr₹3 Cr₹3 Cr

Balance Sheet

Consolidated
Standalone
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2025Mar 2024Mar 2023Mar 2022
₹11 Cr₹20 L₹20 L₹20 L
₹0₹9 Cr₹0₹0
₹15 Cr₹2 Cr₹17 L₹18 L
₹15 Cr₹2 Cr₹17 L₹18 L
₹26 Cr₹11 Cr₹37 L₹38 L
₹1 Cr₹0₹0₹0
₹2 Cr₹2 Cr₹0₹0
₹50 L₹0₹0₹0
-₹68 L-₹3 L-₹4 L-₹4 L
₹4 Cr₹4 Cr₹0₹0
₹45 L₹26 L₹0₹0
₹6 Cr₹5 Cr-₹4 L-₹4 L
₹3 Cr₹2 Cr₹3 Cr₹3 Cr
₹16 Cr₹2 Cr₹3 L₹3 L
₹1 Cr₹0₹0₹0
₹2 Cr₹39 L₹0₹48,000
₹22 Cr₹4 Cr₹3 Cr₹4 Cr
₹55 Cr₹20 Cr₹4 Cr₹4 Cr
₹4 L₹0₹0₹0
₹4 Cr₹2 Cr₹0₹0
₹37 Cr₹14 Cr₹0₹3 Cr
₹6 Cr₹32 L₹0₹57 L
₹31 Cr₹14 Cr₹0₹3 Cr
₹13 L₹6 L₹0₹0
₹2 Cr₹7 L₹3 Cr₹0
₹33 Cr₹14 Cr₹3 Cr₹3 Cr
₹68 L₹27 L₹0₹0
₹15 Cr₹4 Cr₹1 Cr₹1 Cr
₹3 Cr₹1 Cr₹35,000₹34,000
₹87 L₹90 L₹0₹0
₹2 Cr₹18 L₹0₹0
₹22 Cr₹7 Cr₹1 Cr₹1 Cr
₹15 L₹2 Cr-₹2 Cr-₹2 Cr
₹55 Cr₹20 Cr₹4 Cr₹4 Cr
₹5₹87₹19₹19
₹5₹0₹0₹0

Cash Flow

Consolidated
Standalone
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2025Mar 2024Mar 2023Mar 2022
₹13 Cr₹2 Cr-₹62,000₹14 L
₹4 Cr-₹23 L₹0₹57 L
-₹35 L-₹65 L₹1 L-₹61 L
₹16 Cr₹1 Cr₹50,000₹10 L
₹14 Cr₹1 Cr₹1,000₹22,000
-₹18 Cr₹22 L₹0₹0
₹6 Cr-₹47 L₹0₹0
₹2 Cr₹97 L₹1,000₹22,000
₹97 L₹35,000₹34,000₹12,000
₹3 Cr₹97 L₹35,000₹34,000

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Share Price Live Stats

Open (₹)172.88
Volume (₹)1.06 L
High (₹)174.69
Upper Circuit205.81
Low (₹)172.46
Lower Circuit137.21
Prev Close171.51
52W High (₹)175.26
Price172.68
52W Low (₹)98.36

Share Market Cap & Key Ratios Overview

M.Cap (₹)1354.13 Cr
Div. Yield (%)0.00
PE Ratio85.52
Debt to Equity0.15
Price to Book0.00
Book Value4.56
EPS (TTM)2.01
Face Value2.00
ROE (%)68.65

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
APOLLOHOSPNSE
MAXHEALTHNSE
MANIPALHOSNSE
FORTISNSE
ASTERDMNSE
NHNSE
MEDANTANSE
LALPATHLABNSE
KIMSNSE
AGARWALEYENSE
GKSLNSE
LTP
1W Low
1W High
Market cap (₹)
8687.5-151 (-1.71%)
8640
8902
1,26,300Cr
998.5-15.6 (-1.54%)
985.50
1042.10
96,763Cr
732.25-39.4 (-5.11%)
702
784
95,496Cr
911.8-14.95 (-1.61%)
893
929
68,901Cr
786.55+38.15 (5.10%)
745.05
792.05
68,592Cr
1878-54.1 (-2.80%)
1875.90
1949.60
38,439Cr
1473.3+1.1 (0.07%)
1410
1500.10
38,149Cr
1875.9-55.2 (-2.86%)
1855.70
1963
32,259Cr
770.8-0.2 (-0.03%)
748.30
778.55
32,231Cr
510.85+3.05 (0.60%)
502
524.50
16,249Cr
172.68+12.04 (7.50%)
156.64
175.26
1,354Cr

Gujarat Kidney And Super Speciality Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹9.06Cr; with other income of ₹68.9Lakh, profit before interest and tax came to ₹7.63Cr. Interest expense was ₹66.4Lakh; PBT before exceptional items stood at ₹6.96Cr. Basis: consolidated annual results.

Gujarat Kidney And Super Speciality Ltd Quaterly Results Key Takeaways

Gujarat Kidney And Super Speciality Ltd reported ₹34.29Cr total income from operations in Jun 2026, softer than ₹30.58Cr in Mar 2026 but higher than ₹15.26Cr in Jun 2025. Operating profit (before other income, interest and exceptional items) was ₹9.06Cr; with other income of ₹68.9Lakh, profit before interest and tax came to ₹7.63Cr. Interest expense was ₹66.4Lakh, taking profit before tax to ₹6.96Cr. After tax of ₹1.64Cr, profit after tax stood at ₹5.32Cr (vs ₹4.83Cr in Mar 2026 and ₹5.4Cr in Jun 2025).